CMAC
Home
Journal Archive
Subscription
About
About
Author Guidelines
Editorial Board
Peer Review
Publishing Ethics
English
Русский
Nikolay N. Klimko
M.D., D.Sc., Professor
H-index:
31
Scopus Author ID:
6602404074
ORCID:
0000-0001-6095-7531
n_klimko@mail.ru
Research Gate
North-Western State Medical University named after I.I. Mechnikov, Saint-Peterburg Russia
Head of Department of Clinical Mycology, Allergy and Immunology
Latest
Candida
spp. peritonitis (clinical cases, register analysis and literature review)
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):311-320
Invasive aspergillosis in patients with COVID-19 in intensive care units: results of a multicenter study
Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(4):295-302
Combination of invasive aspergillosis and mucormycosis in children: a case report and the results of a multicenter study
Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(1):14-22
Mucormycosis of the bones of the facial skull, nasal cavity and par anasal sinuses in patients with COVID19
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(4):347-358
Mucormycosis following COVID19: clinical case and literature review
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):255-262
Pharmacoepidemiology of antimicrobial agents in pregnant women: a non-interventional retrospective study
Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(1):67-72
Pharmacoeconomic Analysis of Anidulafungin (Eraxis®) Use in the Treatment of Invasive Candidiasis
Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(3):235-244
Pharmacoeconomic Analysis of Micafungin (Mycamin®) Use in the Treatment of Patients with Invasive Candidiasis
Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):267-278
Clinical and Pharmacoeconomic Analysis of the Treatment of Invasive Candidiasis in Intensive Care Units
Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(3):264-274
Clinical and Economical Expediency of Posaconazole Comparing with Fluconazole and Itraconazole in Primary Prophylaxis of Systemic Mycoses in Severe Neutropenic Patients
Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(2):170-182
Analysis of Antifungal Agents Consumption in Large Clinic
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):355-361
In Vitro Activity of Fluconazole and Voriconazole Against More Than 10000 Yeast Strains: Results of 5-years Prospective ARTEMIS Disk Study in Russia
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):345-354
Efficacy and Safety of Caspofungin in Hematological Patients with Invasive Aspergillosis
Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(2):153-161
Efficacy and Safety of Combined Antimycotic Therapy of Invasive Aspergillosis in Children
Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):383-388
Clinical and Pharmacoeconomic Analysis of the Fluconazole Use for the Prophylaxis of Invasive Candidiasis in Very-Low-Birth Weight Infants
Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(3):270-279
Efficacy and Safety of Caspofungin in Children with Invasive Fungal Infections
Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(2):193-200
First Russian Experience of Successful Use of Caspofungin in Invasive Candidiasis in Patient with Severe Hepatic Failure (Clinical case)
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(4):403-409
Candida Infections in Very-Low-Birth-Wieight Neonates
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(2):189-196
Risk Factors for Development of Candidemia in Neonates with Gestational Age Less Than 32 Weeks
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(1):97-102
Epidemiology of Candidiasis Causative Agents and Their Susceptibility to Azoles: Results of ARTEMIS Disk Study in Russia
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(1):68-76
Comments on IDSA Guidelines for the Management of Patients with Candidiasis. Focus on Clinical Use of Caspofungin
Clinical Microbiology and Antimicrobial Chemotherapy.2004; 6(4):394-396
Prophylactic and Empirical Use of Antifungals in Neonates
Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):354-359
New Drugs for the Treatment of Invasive Mycoses
Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):342-353
Candidemia In Hospitalized Patients In Saint-Petersburg
Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):15-21
Cite
×